What's Happening?
Precision Biologics Manufacturing, a subsidiary of New Horizon Medical Solutions, has announced the groundbreaking of a new manufacturing facility in Southern Nevada. This facility is set to expand the production of advanced biologics technology and is expected to create between 200 to 300 jobs in the Las Vegas Valley by the second half of 2026. The groundbreaking ceremony, held on September 30, 2025, was attended by biologics executives, local politicians, and team members from New Horizon Medical Solutions. The facility will be GMP-compliant and will serve as a center for advanced engineering, development, testing, and production. It will also support training and compliance across the company and the industry. This development is part of New Horizon's strategy to strengthen its position as a leader in advanced biologics and wound care.
Why It's Important?
The establishment of this new facility is significant for several reasons. Firstly, it represents a substantial investment in the local economy of Southern Nevada, potentially creating thousands of jobs in the medical sector. This aligns with the growth objectives of local institutions such as UNLV and the Kirk Kirkorian School of Medicine. Additionally, the facility will enhance the U.S.-based manufacturing capabilities of New Horizon Medical Solutions, supporting the company's long-term growth and innovation in the biologics sector. This move is also expected to bolster the local medical ecosystem, providing new opportunities for Nevada families and contributing to the state's burgeoning medical market.
What's Next?
As the facility becomes operational, it is expected to play a crucial role in the expansion of New Horizon's biologics portfolio, which has recently added five new products. The company will likely continue to invest in U.S.-based manufacturing, further solidifying its position in the global wound care and advanced biologics sectors. The impact of this facility on the local economy and job market will be closely monitored by state leaders and industry stakeholders, who have been advocating for such developments over the past two decades.
